The Ochsner Hematology Oncology Training Program is an ACGME-accredited combined Hematology and Medical Oncology program that offers dual-specialty training. We offer three positions in each first-year class. The program is three years in length. Fellows spend a majority of their time in clinical training, with 3-6 months spent in mentored research. In addition, there is ongoing experience in the hematologic malignancies/stem cell transplant program, both inpatient and outpatient.

Fellows participate in both blood bank and hematopathology activities. Fellows are provided with access to ASCO University as well as all ASH educational materials.

Both the ASCO and ASH in-service training exams are utilized as learning tools.

There is a travel stipend for fellows to attend appropriate educational conferences and support for travel if research is presented at national meetings.

There is a robust outpatient clinic activity with approximately 5000 patients with new cancer diagnoses seen each year. Those outpatient activities take place in the Gayle and Tom Benson Cancer Center, a separate, dedicated outpatient facility housing clinics and the infusion center. An expansion to the cancer center broke ground in late 2017; the result of a $20 million gift from the Bensons. It will double the size of the center, adding 100,000 square feet over five floors. 26 personalized and semi-private chemo infusion stations and dedicated infusion and clinic spaces for bone marrow transplant patients will be added.

New patient wellness space will include areas dedicated to yoga, meditation, patient education and support groups. Future plans include a cosmetic and wig boutique, food and beverage options and services such as massage and acupuncture.

Multidisciplinary clinics in breast, lung, head and neck, and genitourinary cancers are in place.

The Ochsner Cancer Institute (OCI) was founded in 1981 and houses the clinical research and supportive care programs. Ochsner is a recipient of a National Cancer Institute NCORP Grant for clinical cancer research. Our cancer research program includes both NCI sponsored cooperative group trials as well as pharmaceutical industry trials. In addition, in 2016 a phase 1 clinical trials program (Precision Cancer Therapies Program) was instituted in collaboration with T-Gen (Phoenix, Arizona) .

In addition to the Benson Cancer Center, the Ochsner Campus also has the Lieselotte Tansey Breast Cancer, the first facility in the New Orleans area to be fully accredited by the National Accreditation Program for Breast Centers (NAPBC). The Tansey Center houses breast imaging and the multi-disciplinary breast clinic and will move to the newly expanded space in the Benson Cancer Center.

The Ochsner Leukemia, Blood, and Bone Marrow Transplantation Program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) for adults undergoing autologous stem cell transplants. Both autologous and allogeneic transplants are performed in our center.

Ochsner Medical Center is ranked in the Top 10% in the nation for cancer by CareChex, a Division of Comparion. We are also named “High Performing” in cancer care by U.S. News & World Report.

We are participating in the ERAS (Electronic Residency Application Service). Our evaluation of your application will be enhanced by a description of your research interests and career plans in the form of a Personal Statement.